Global Blood Therapeutics, Inc. Research and Development Expense
Global Blood Therapeutics, Inc. reported Research and Development Expense of $64.78 million for the 3-month period ending 2022-06-30, per its 10-Q filed 2022-08-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2022-08-08
- Global Blood Therapeutics, Inc. research and development expense for the quarter ending 2022-06-30 was $64.78M, a 25.09% increase year-over-year.
- Global Blood Therapeutics, Inc. research and development expense for the quarter ending 2022-03-31 was $52.83M, a 3.89% increase year-over-year.
- Global Blood Therapeutics, Inc. research and development expense for the quarter ending 2021-12-31 was $58.97M, a 43.58% increase year-over-year.
- Global Blood Therapeutics, Inc. research and development expense for the quarter ending 2021-09-30 was $50.53M, a 25.71% increase year-over-year.
- Global Blood Therapeutics, Inc. research and development expense for fiscal 2021 was $212.13M, a 36.75% increase from fiscal 2020.
- Global Blood Therapeutics, Inc. research and development expense for fiscal 2020 was $155.12M, a 11.13% decline from fiscal 2019.
- Global Blood Therapeutics, Inc. research and development expense for fiscal 2019 was $174.56M, a 32.94% increase from fiscal 2018.
- Global Blood Therapeutics, Inc. research and development expense for fiscal 2018 was $131.31M, a 49.54% increase from fiscal 2017.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2022-06-30 | $64.78M 10-Q · filed 2022-08-08 | $117.61M 10-Q · filed 2022-08-08 | $176.57M derived: sum of 3 quarters · filed 2022-08-08 | $227.10M derived: sum of 4 quarters · filed 2022-08-08 | ||||
| 2022-03-31 | $52.83M 10-Q · filed 2022-05-04 | $111.80M derived: sum of 2 quarters · filed 2022-05-04 | $162.33M derived: sum of 3 quarters · filed 2022-05-04 | $214.11M derived: sum of 4 quarters · filed 2022-08-08 | ||||
| 2021-12-31 | $58.97M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $109.49M derived: sum of 2 quarters · filed 2022-02-23 | $161.28M derived: sum of 3 quarters · filed 2022-08-08 | $212.13M 10-K · filed 2022-02-23 | ||||
| 2021-09-30 | $50.53M 10-Q · filed 2021-11-04 | $102.31M derived: sum of 2 quarters · filed 2022-08-08 | $153.17M 10-Q · filed 2021-11-04 | $194.24M derived: sum of 4 quarters · filed 2022-08-08 | ||||
| 2021-06-30 | $51.78M 10-Q · filed 2022-08-08 | $102.64M 10-Q · filed 2022-08-08 | $143.71M derived: sum of 3 quarters · filed 2022-08-08 | $183.91M derived: sum of 4 quarters · filed 2022-08-08 | ||||
| 2021-03-31 | $50.86M 10-Q · filed 2022-05-04 | $91.92M derived: sum of 2 quarters · filed 2022-05-04 | $132.12M derived: sum of 3 quarters · filed 2022-05-04 | $166.21M derived: sum of 4 quarters · filed 2022-05-04 | ||||
| 2020-12-31 | $41.07M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $81.26M derived: sum of 2 quarters · filed 2022-02-23 | $115.35M derived: sum of 3 quarters · filed 2022-02-23 | $155.12M 10-K · filed 2022-02-23 | ||||
| 2020-09-30 | $40.20M 10-Q · filed 2021-11-04 | $74.28M derived: sum of 2 quarters · filed 2021-11-04 | $114.05M 10-Q · filed 2021-11-04 | $179.05M derived: sum of 4 quarters · filed 2022-02-23 | ||||
| 2020-06-30 | $34.09M 10-Q · filed 2021-08-03 | $73.86M 10-Q · filed 2021-08-03 | $138.85M derived: sum of 3 quarters · filed 2022-02-23 | $177.94M derived: sum of 4 quarters · filed 2022-02-23 | ||||
| 2020-03-31 | $39.77M 10-Q · filed 2021-05-05 | $104.77M derived: sum of 2 quarters · filed 2022-02-23 | $143.85M derived: sum of 3 quarters · filed 2022-02-23 | $179.86M derived: sum of 4 quarters · filed 2022-02-23 | ||||
| 2019-12-31 | $64.99M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $104.08M derived: sum of 2 quarters · filed 2022-02-23 | $140.09M derived: sum of 3 quarters · filed 2022-02-23 | $174.56M 10-K · filed 2022-02-23 | ||||
| 2019-09-30 | $39.09M 10-Q · filed 2020-11-05 | $75.10M derived: sum of 2 quarters · filed 2020-11-05 | $109.56M 10-Q · filed 2020-11-05 | $146.33M derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2019-06-30 | $36.01M 10-Q · filed 2020-08-05 | $70.48M 10-Q · filed 2020-08-05 | $107.24M derived: sum of 3 quarters · filed 2021-02-24 | $140.27M derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2019-03-31 | $34.47M 10-Q · filed 2020-05-06 | $71.23M derived: sum of 2 quarters · filed 2021-02-24 | $104.26M derived: sum of 3 quarters · filed 2021-02-24 | $135.83M derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2018-12-31 | $36.76M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $69.79M derived: sum of 2 quarters · filed 2021-02-24 | $101.36M derived: sum of 3 quarters · filed 2021-02-24 | $131.31M 10-K · filed 2021-02-24 | ||||
| 2018-09-30 | $33.03M 10-Q · filed 2019-11-07 | $64.60M derived: sum of 2 quarters · filed 2019-11-07 | $94.54M 10-Q · filed 2019-11-07 | $125.84M derived: sum of 4 quarters · filed 2020-02-26 | ||||
| 2018-06-30 | $31.57M 10-Q · filed 2019-08-07 | $61.52M 10-Q · filed 2019-08-07 | $92.81M derived: sum of 3 quarters · filed 2020-02-26 | $113.76M derived: sum of 4 quarters · filed 2020-02-26 | ||||
| 2018-03-31 | $29.94M 10-Q · filed 2019-05-10 | $61.24M derived: sum of 2 quarters · filed 2020-02-26 | $82.19M derived: sum of 3 quarters · filed 2020-02-26 | $100.47M derived: sum of 4 quarters · filed 2020-02-26 | ||||
| 2017-12-31 | $31.29M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $52.25M derived: sum of 2 quarters · filed 2020-02-26 | $70.52M derived: sum of 3 quarters · filed 2020-02-26 | $87.81M 10-K · filed 2020-02-26 | ||||
| 2017-09-30 | $20.95M 10-Q · filed 2018-11-06 | $39.23M derived: sum of 2 quarters · filed 2018-11-06 | $56.51M 10-Q · filed 2018-11-06 | $77.42M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-06-30 | $18.28M 10-Q · filed 2018-08-02 | $35.56M 10-Q · filed 2018-08-02 | $56.47M derived: sum of 3 quarters · filed 2019-02-27 | $71.61M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-03-31 | $17.28M 10-Q · filed 2018-05-07 | $38.19M derived: sum of 2 quarters · filed 2019-02-27 | $53.34M derived: sum of 3 quarters · filed 2019-02-27 | $66.76M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2016-12-31 | $20.91M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $36.05M derived: sum of 2 quarters · filed 2019-02-27 | $49.48M derived: sum of 3 quarters · filed 2019-02-27 | $62.16M 10-K · filed 2019-02-27 | $61.21M 10-K · filed 2017-03-13 | |||
| 2016-09-30 | $15.41M 10-Q · filed 2017-11-02 | $28.57M derived: sum of 2 quarters · filed 2017-08-07 | $41.26M 10-Q · filed 2017-11-02 | $40.85M 10-Q · filed 2016-11-09 | $52.39M derived: sum of 4 quarters · filed 2018-02-27 | |||
| 2016-06-30 | $13.43M 10-Q · filed 2017-08-07 | $13.29M 10-Q · filed 2016-08-10 | $25.84M 10-Q · filed 2017-08-07 | $25.70M 10-Q · filed 2016-08-10 | $37.24M derived: sum of 3 quarters · filed 2018-02-27 | $49.35M derived: sum of 4 quarters · filed 2018-02-27 | ||
| 2016-03-31 | $12.41M 10-Q · filed 2017-05-01 | $23.82M derived: sum of 2 quarters · filed 2018-02-27 | $35.92M derived: sum of 3 quarters · filed 2018-02-27 | $43.00M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2015-12-31 | $11.40M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $23.51M derived: sum of 2 quarters · filed 2018-02-27 | $30.59M derived: sum of 3 quarters · filed 2018-02-27 | $36.66M 10-K · filed 2018-02-27 | ||||
| 2015-09-30 | $12.11M 10-Q · filed 2016-11-09 | $19.19M derived: sum of 2 quarters · filed 2016-11-09 | $25.26M 10-Q · filed 2016-11-09 | $29.32M derived: sum of 4 quarters · filed 2017-03-13 | ||||
| 2015-06-30 | $7.08M 10-Q · filed 2016-08-10 | $13.15M 10-Q · filed 2016-08-10 | $17.21M derived: sum of 3 quarters · filed 2017-03-13 | $21.28M derived: sum of 4 quarters · filed 2017-03-13 | ||||
| 2015-03-31 | $6.07M 10-Q · filed 2016-05-12 | $10.13M derived: sum of 2 quarters · filed 2017-03-13 | $14.20M derived: sum of 3 quarters · filed 2017-03-13 | $18.52M derived: sum of 4 quarters · filed 2017-03-13 | ||||
| 2014-12-31 | $4.06M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | $8.13M derived: sum of 2 quarters · filed 2017-03-13 | $12.45M derived: sum of 3 quarters · filed 2017-03-13 | $16.32M 10-K · filed 2017-03-13 | ||||
| 2014-09-30 | $4.07M 10-Q · filed 2015-11-12 | $8.38M derived: sum of 2 quarters · filed 2015-11-12 | $12.26M 10-Q · filed 2015-11-12 | |||||
| 2014-06-30 | $4.32M 10-Q · filed 2015-09-24 | $8.19M 10-Q · filed 2015-09-24 | ||||||
| 2013-12-31 | $12.86M 10-K · filed 2016-03-29 |